Tango Therapeutics, Inc.

TNGXNASDAQ • USD
22.40 USD
↘ 1.78 (7.36%)🟢LIVE (AS OF 02:25 PM EST)
🟢Market: OPEN

TNGX is currently priced at $22.40. The stock presents a mixed profile: our models indicate a Buy for technical indicators, while underlying fundamentals flash a Sell. This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On valuation, TNGX trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Nov 16, 2026.

Open?$24.08
High?$24.77
Low?$22.21
Prev. Close?$24.17
Volume?837.7K
Avg. Volume?4.1M
VWAP?$22.77
Rel. Volume?0.20x
Bid / Ask
Bid?$22.14 × 100
Ask?$22.38 × 100
Spread?$0.24
Midpoint?$22.26
Valuation & Ratios
Market Cap?4.1B
Shares Out?169.5M
Float?140.4M
Float %?83.3%
P/E Ratio?N/A
P/B Ratio?4.18
EPS?-$1.23
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
Employees
137
Market Cap
4.1B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2021-08-11
Address
201 BROOKLINE AVENUE
BOSTON, MA 02215
Phone: (857) 320-4900
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
23
Short Sent.?
31
Piotroski F-Score?0/9Weak
Altman Z-Score?45.46Safe
Confidence?52%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?34.35%Squeeze Risk
Short Interest?48.2M
Days to Cover?9.7
Free Float140.4M
Avg Daily Volume5.0M
Settlement Date2026-10-30
Financial Health
Current Ratio?39.45Strong
Quick Ratio?39.45Strong
Cash Ratio?3.45Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
43
4.18FAIR▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-17.7CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
7
-21.2%WEAK▾
ROA?
S&P
3
-20.1%WEAK▾
Cash Flow & Enterprise
FCF?$-150364000
Enterprise Value?$4.0B
Fundamentals ratios updated end of day